Stock NRX NUREXONE BIOLOGIC INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company NurExone Biologic Inc.

Equities

NRX

CA67059R1091

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 01:28:03 04/06/2024 am IST 		5-day change 1st Jan Change
0.51 CAD -1.92% Intraday chart for NurExone Biologic Inc. +4.08% +72.88%
25/04 NurExone Biologic Announces OTCQB Listing And DTC Eligibility MT
02/04 NurExone Biologic Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ExoTherapy production platform and products for a global market. It is involved in the development of ExoPTEN, the first ExoTherapy-based product for acute Spinal Cord Injuries (SCI). The Company is developing treatment for the reversal or reduction of paralysis following spinal cord injury (SCI) using Exosomes (membrane-bound extracellular vesicles). This technology, subject to conducting clinical trials and receiving Food and Drug Administration (the FDA) approval, can be used in various conditions such as SCI, Brain Trauma Injury (BTI), and potentially other brain and neurological indications.

Managers

Managers TitleAgeSince
Lior Shaltiel CEO
 Chief Executive Officer - 01/21/01
Eran Ovadya DFI
 Director of Finance/CFO - 15/22/15

Members of the board

Members of the board TitleAgeSince
Jay Richardson BRD
 Director/Board Member 78 03/22/03
Gadi Riesenfeld BRD
 Director/Board Member 79 06/23/06
Yoram Drucker CHM
 Chairman 59 01/20/01
Oded Orgil BRD
 Director/Board Member 57 15/22/15
Lior Shaltiel CEO
 Chief Executive Officer - 01/21/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 67,105,428 63,578,695 ( 94.74 %) 0 94.74 %

Shareholders

NameEquities%Valuation
Yoram Drucker
6.604 %
3,655,000 6.604 % 2 M $
Ron Abraham Mayron
1.229 %
680,000 1.229 % 317 560 $
Lior Shaltiel
0.7680 %
425,000 0.7680 % 198 475 $
Eran Ovadya
0.7680 %
425,000 0.7680 % 198 475 $
Jay Richardson
0.1265 %
70,000 0.1265 % 32 690 $
Gadi Riesenfeld
0.000000 %
0 0.000000 % - $
Oded Orgil
0.000000 %
0 0.000000 % - $

Company contact information

NurExone Biologic, Inc.

9 Mezada Street BSR 3 Tower

5120109, Bnei-Brak

+

http://www.nurexone.com
address NurExone Biologic Inc.(NRX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3744 USD
Average target price
2.907 USD
Spread / Average Target
+676.54%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
NUREXONE BIOLOGIC INC. Stock NurExone Biologic Inc.
+72.88% 2.51Cr
MODERNA, INC. Stock Moderna, Inc.
+48.64% 5.67TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-6.44% 3.94TCr
LONZA GROUP AG Stock Lonza Group AG
+39.50% 3.9TCr
CELLTRION, INC. Stock Celltrion, Inc.
-11.17% 2.69TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+14.28% 2.67TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.40% 1.9TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.96% 1.23TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.64% 1.23TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.04% 1.2TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. NRX Stock
  4. Company NurExone Biologic Inc.